Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Lexeo Therapeutics (LXEO) Leases (2022 - 2026)

Lexeo Therapeutics' Leases history spans 2 years, with the latest figure at $1.8 million for Q4 2023.

  • On a quarterly basis, Leases fell 83.54% to $1.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.8 million, a 83.54% decrease, with the full-year FY2023 number at $1.8 million, down 83.54% from a year prior.
  • Leases hit $1.8 million in Q4 2023 for Lexeo Therapeutics, down from $1.8 million in the prior quarter.
  • Over the last five years, Leases for LXEO hit a ceiling of $10.7 million in Q4 2022 and a floor of $1.8 million in Q4 2023.